Regression of brain metastases from breast cancer with eribulin: a case report

Overview of attention for article published in BMC Research Notes, December 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 30 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

USE OF ERIBULIN AND MTOR INHIBITORS AS COMBINATION THERAPY FOR THE TREATMENT OF CANCER

Application EP-3113775-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.